Healthcare Policy

Dáil Éireann Debate, Tuesday - 29 September 2026

• Debates
• Find a debate
  • Dáil debates
  • Seanad debates
  • Committee debates
• Find a vote
  • Dáil votes
  • Seanad votes
  • Committee votes
• Parliamentary questions
  • Written questions
  • Oral questions
• Search tips
• Utterances having an adverse effect

Tuesday, 29 September 2026

Questions (842)

Naoise Ó Muirí

Question:

842. Deputy Naoise Ó Muirí asked the Minister for Health if a medication (details supplied) will be approved for reimbursement and use within the public health service for patients with HER2-mutated non-small cell lung cancer; and if she will make a statement on the matter. [68860/26]

Written answers

Minister for Health

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

• Previous Answer
• Next Answer